Department of Biomedical Sciences, University of Sassari, Sassari, Italy -
Department of Medical, Surgical, and Experimental Sciences, University of Sassari, Sassari Italy.
Panminerva Med. 2022 Jun;64(2):228-234. doi: 10.23736/S0031-0808.21.04144-6. Epub 2021 Jan 26.
While a number of individual patient characteristics are associated with survival in idiopathic pulmonary fibrosis (IPF), their incorporation into combined indexes, such as the GAP index, has been shown to increase the predictive capacity. It is unknown whether the predictive capacity of GAP-derived indexes that also include anthropometric and exercise parameters is superior to the original instrument.
We tested the four-year survival predictive capacity of a modified, adimensional and multiplicative GAP index (IC4) that included percent forced vital capacity (FVC%), diffusing capacity of the lung for carbon monoxide (DLCO%), Body Mass Index (BMI), and six-minute walk distance (6MWD) in 90 IPF patients recruited from two centers in France and Italy.
In ROC comparisons, the AUC of the IC4 (0.859, 95% CI 0.770-0.924 P<0.0001) was significantly higher than the AUCs of the individual components, their two-three component combinations, and the original GAP index, with 77% sensitivity and 89% specificity. Mean survival was 14.0±11.7, 23.2±12.7, 34.9±14.8, and 40.8±12.9 months, and survival rate was 0%, 14%, 39% and 73%, in IC4 quartile 1, 2, 3, and 4, respectively.
The IC4, a combined non-dimensional index incorporating FVC%, DLCO%, BMI and 6MWD, provides superior capacity to predict mortality, when compared to its individual components, their other combinations, and the GAP index, in patients with IPF.
虽然一些个体患者特征与特发性肺纤维化(IPF)的生存相关,但将这些特征纳入 GAP 指数等综合指数已被证明可以提高预测能力。目前尚不清楚是否包括人体测量和运动参数的 GAP 衍生指数的预测能力优于原始仪器。
我们在法国和意大利的两个中心招募的 90 名特发性肺纤维化患者中,测试了改良的、无维的、乘法 GAP 指数(IC4)的四年生存率预测能力,该指数包括用力肺活量百分比(FVC%)、一氧化碳弥散量(DLCO%)、体重指数(BMI)和 6 分钟步行距离(6MWD)。
在 ROC 比较中,IC4 的 AUC(0.859,95%CI 0.770-0.924,P<0.0001)明显高于各单独成分、两两成分组合和原始 GAP 指数的 AUC,其敏感性为 77%,特异性为 89%。平均生存时间分别为 14.0±11.7、23.2±12.7、34.9±14.8 和 40.8±12.9 个月,IC4 四分位数 1、2、3 和 4 的生存率分别为 0%、14%、39%和 73%。
与各单独成分、其他组合以及 GAP 指数相比,IC4 是一种综合无维指数,纳入 FVC%、DLCO%、BMI 和 6MWD,可更好地预测 IPF 患者的死亡率。